Spring direct naar de hoofdnavigatie of de inhoud
‘To explore, together with a client, how the best IP protection can be obtained is for me the logical next step after an invention has been made.’
Frits Michiels

Frits Michiels

  • Life Sciences
  • European and Dutch Patent Attorney
  • Valuation specialist
  • Partner

Frits Michiels has had an extensive scientific career in both knowledge institutes and biotech companies. From 2004, he was employed as IP manager at Galapagos Genomics BV and subsequently also at other Dutch biotech startups, such as Agendia and Merus. He has worked for V.O. since 2006.

Continue reading

He is specialized in biochemistry, molecular biology, cell biology, diagnostics, signal transduction, and medical biotechnology. His clients are primarily knowledge institutes and start ups. He is involved in patent prosecution and strategic advice.

Working experience

  • Patent Attorney, V.O. (2006-present)
  • Merus (2006)
  • Galapagos Genomics (1999-2005)
  • Senior Scientist at the Netherlands Cancer Institute (1994-1998)
  • Post-Doc, Amsterdam Medical Center (1991-1993)
  • PhD research at Max Planck Institute for Biochemistry, Munich (1985-1990)

Education

  • PhD in Genetics, Radboud University Nijmegen (1990)
  • MSc in Microbiology, Radboud University Nijmegen (1984)

Publications

  • Michiels, GAM Damages extended to after termination of a tort. MIP Vol 205: 94-95 (2011)
  • JP ten Klooster, EE Evers, L Janssen, LM Machesky, F Michiels, P Hordijk and JG Collard. Biochem J. 397, 39–45 (2006)
  • GJ Arts, E Langemeijer, R Tissingh, L Ma, H Pavliska, K Dokic, R Dooijes, E Mesić, R Clasen, F Michiels, J van der Schueren, M Lambrecht, S Herman, R Brys, K Thys, M Hoffmann, P Tomme, H van Es. Genome Res 13, 2325-32 (2003)
  • A Malliri, RA van der Kammen, K Clark, M van der Valk, F Michiels & JG Collard. Nature 417, 867-871 (2002)
  • F Michiels et al. Nature Biotech 20, 1154-1157 (2002)
  • R Engers, E Springer, F Michiels, JG Collard, HE Gabbert. J Biol Chem 276, 41889-97 (2001)
  • WO2002057463 Swap/counter selection; a rapid cloning
  • WO2002070744 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds method
  • WO2005124342 Methods and means for treatment of osteoarthritis

Languages

  • English
  • Dutch
  • German

Also see these experts

Tamara Elmore

Tamara Elmore

  • European and Dutch Patent Attorney
  • United States Patent Agent
  • Partner
Saskia van Doorn

Saskia van Doorn

  • European and Dutch Patent Attorney
  • Senior Associate
More experts

News

Put your hands together for the Nobel Prize in Chemistry 2021 – How fundamental research can lead to new opportunities in innovation

Last year the Nobel Prize in Chemistry goes to Benjamin List and David MacMillan for ‘the development of asymmetric organocatalysis’. This is a fine example of a fundamental scientific discovery that has quickly found a practical application.Continue reading

First meeting of the Administrative Committee of the new European Patent Court

On 22 February 2022, the first meeting of the Administrative Committee of the new European Patent Court (the Unified Patent Court) took place.Continue reading

Money Losing Party Court

V.O. model quickly estimates patent value

How do you estimate the economic value of a patent? V.O. has developed a model that arrives at an estimation based on various factors. This allows companies to have a better understanding of how much their patent can deliver for them.Continue reading

Events

Knowledge for Growth 2022

Gent ICC, Familie van Rysselberghedreef, Ghent, Belgium

The cream of the Belgian life sciences community attends flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech, agricultural and chemical industry as well as investors, universities, topnotch research institutes, policymakers and competence providers. Continue reading

Dutch Lifes Sciences Conference 2022

CORPUS Congress Centre, Willem Einthovenstraat, Oegstgeest, Netherlands

The foremost life sciences business network event in the Netherlands. Continue reading

Unitary Patent Package Conference 2022

Van der Valk Hotel Amsterdam - Amstel, Joan Muyskenweg, Amsterdam, Netherlands

Finally the Unitary Patent and the Unified Patent Court will become reality! In January 2022 Austria ratified as the 13th country and the new system will be up and running in the second half of 2022. So, patent professionals get prepared! Continue reading